Assessing The Impact Of Clinical Pharmacists On Pharmacology-Related Issues In Acute Coronary Syndrome: A Review

Abstract

“Acute Coronary Syndrome (ACS)” are more likely to have drug-related problems (DRP) because comorbidities and complications that necessitate taking multiple drugs are frequently present.  Drug-related problems (DRPs) may happen at any point during the medication process, from prescription to post-treatment care. Within a multidisciplinary healthcare team, clinical pharmacists are crucial to the treatment of patients with ACS. Medication reconciliation services are offered by pharmacists, according to evaluation. Patient outcomes improve when patients are informed about their medications and given collaborative medication management, particularly during the transition of care. This includes but is not limited to a decline in readmissions and hospitalisations. It is expected that as novel treatments and creative care for ACS patients are introduced, the role of the pharmacist will continue to develop. This evaluation assesses a clinical pharmacist’s contribution to the treatment of acute coronary syndrome-related medication problems.